Direct inhibition of EGF receptor activation in vascular endothelial cells by gefitinib ('Iressa', ZD1839).
about
Overexpression and activation of epidermal growth factor receptor in hemangioblastomas.Phosphorylated epidermal growth factor receptor on tumor-associated endothelial cells in human renal cell carcinoma is a primary target for therapy by tyrosine kinase inhibitors.Palm tocotrienols decrease levels of pro-angiogenic markers in human umbilical vein endothelial cells (HUVEC) and murine mammary cancer cells.Quantitative immunohistochemistry for evaluating the distribution of Ki67 and other biomarkers in tumor sections and use of the method to study repopulation in xenografts after treatment with paclitaxel.Antineovascular therapy, a novel antiangiogenic approach.Both stromal cell and colonocyte epidermal growth factor receptors control HCT116 colon cancer cell growth in tumor xenografts.Efficacy of epidermal growth factor receptor-targeted molecular therapy in anaplastic thyroid cancer cell lines.PtdIns-4,5-P2 as a potential therapeutic target for pathologic angiogenesis.STAT3-mediated coincidence detection regulates noncanonical immediate early gene induction.Antitumor effect of vandetanib through EGFR inhibition in head and neck squamous cell carcinomaCombined EGFR- and notch inhibition display additive inhibitory effect on glioblastoma cell viability and glioblastoma-induced endothelial cell sprouting in vitro.Dipalmitoylation of radicicol results in improved efficacy against tumor growth and angiogenesis in vivo.Complementary effects of ciclopirox olamine, a prolyl hydroxylase inhibitor and sphingosine 1-phosphate on fibroblasts and endothelial cells in driving capillary sprouting.
P2860
Q34083790-B3C32D1F-3973-44A8-8CCC-5A3F4F1F02B1Q35082185-EA66E385-16B0-49BE-8EB7-FFB9CA8EB402Q35648921-5EE72F0D-C2EF-44D7-9FEF-BFC7A5B24095Q35949779-7467C32C-1DD1-4B4E-88DB-C36BCFF1DAE0Q36066281-B5BE2D3B-421C-4CFF-AD95-9D542897ADAAQ36486683-EE5348DB-855A-47F7-9DB0-50732F34F806Q36616462-FCC9FF17-74AD-4A24-831A-3E76C660040BQ36764870-DFB456EB-6787-440B-9558-6C88942A9780Q36796847-9152A095-92F8-4399-81E9-58537C84EC3DQ36909227-5B6CE464-6B61-4455-AF71-62C6BCA715D6Q39818316-8FAA5F98-15CF-4C74-AD05-FD0334E2811CQ40181971-A30C125F-58A7-4457-A2CF-D02A8A31DF3CQ54662271-9B7177E4-8CFB-40DF-8B00-6C946DD03A94
P2860
Direct inhibition of EGF receptor activation in vascular endothelial cells by gefitinib ('Iressa', ZD1839).
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Direct inhibition of EGF recep ...... gefitinib ('Iressa', ZD1839).
@en
Direct inhibition of EGF recep ...... gefitinib ('Iressa', ZD1839).
@nl
type
label
Direct inhibition of EGF recep ...... gefitinib ('Iressa', ZD1839).
@en
Direct inhibition of EGF recep ...... gefitinib ('Iressa', ZD1839).
@nl
prefLabel
Direct inhibition of EGF recep ...... gefitinib ('Iressa', ZD1839).
@en
Direct inhibition of EGF recep ...... gefitinib ('Iressa', ZD1839).
@nl
P2093
P2860
P1433
P1476
Direct inhibition of EGF recep ...... gefitinib ('Iressa', ZD1839).
@en
P2093
Akira Hirata
Hisanori Uehara
Keisuke Izumi
Mayumi Ono
Michihiko Kuwano
Seiji Naito
P2860
P304
P356
10.1111/J.1349-7006.2004.TB02496.X
P577
2004-07-01T00:00:00Z